VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Strong Trading Volume

VanEck Pharmaceutical ETF (NASDAQ:PPH) saw unusually-strong trading volume on Monday . Approximately 149,941 shares were traded during trading, an increase of 9% from the previous session’s volume of 138,039 shares.The stock last traded at $96.68 and had previously closed at $96.66.

VanEck Pharmaceutical ETF Stock Up 0.8 %

The firm has a 50 day moving average price of $94.46 and a 200 day moving average price of $91.25. The stock has a market cap of $656.95 million, a PE ratio of 21.04 and a beta of 0.72.

VanEck Pharmaceutical ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, July 5th. Investors of record on Monday, July 1st were given a dividend of $0.3558 per share. The ex-dividend date of this dividend was Monday, July 1st.

Hedge Funds Weigh In On VanEck Pharmaceutical ETF

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Avestar Capital LLC purchased a new stake in shares of VanEck Pharmaceutical ETF in the 4th quarter valued at $4,284,000. Independent Advisor Alliance grew its stake in VanEck Pharmaceutical ETF by 100.8% during the 4th quarter. Independent Advisor Alliance now owns 98,473 shares of the company’s stock worth $7,939,000 after buying an additional 49,423 shares during the last quarter. Assetmark Inc. increased its stake in VanEck Pharmaceutical ETF by 107.5% in the fourth quarter. Assetmark Inc. now owns 5,485 shares of the company’s stock valued at $446,000 after purchasing an additional 2,841 shares during the period. WT Wealth Management raised its holdings in shares of VanEck Pharmaceutical ETF by 11.7% in the fourth quarter. WT Wealth Management now owns 39,613 shares of the company’s stock valued at $3,223,000 after buying an additional 4,155 shares during the last quarter. Finally, Comerica Bank boosted its stake in shares of VanEck Pharmaceutical ETF by 39.4% during the first quarter. Comerica Bank now owns 1,337 shares of the company’s stock worth $121,000 after buying an additional 378 shares during the period.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.